Jazz Music and Mindfulness for Chronic Pain
1 other identifier
interventional
90
1 country
1
Brief Summary
Chronic pain, including spinal pain and osteoarthritis, is the leading cause of years lived with disability world-wide and the costliest health condition in the U.S. today. Compounding these concerns, opioid analgesics remain the primary pharmacological treatment for chronic pain. An estimated 21-29% of chronic pain patients receiving long-term opioid therapy develop opioid misuse, and opioid misuse portends addiction and overdose. Clearly, chronic pain patients need better, non-addictive treatment options designed to reverse the downward spiral of chronic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable chronic-pain
Started Aug 2023
Typical duration for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2023
CompletedStudy Start
First participant enrolled
August 1, 2023
CompletedFirst Posted
Study publicly available on registry
August 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedFebruary 2, 2026
January 1, 2026
2.7 years
July 28, 2023
January 29, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Pain Intensity portion of The Pain, Enjoyment of Life and General Activity (PEG) scale
The Pain, Enjoyment of Life and General Activity (PEG) scale will be used to assess the magnitude of pain sensations experienced by participants in the past week. Range 0-10, where higher score equals more pain.
4 weeks
Study Arms (3)
Jazz Only
ACTIVE COMPARATORJazz Group 1: Participants in this group will watch an introduction to jazz appreciation video prior to the 4-week intervention.
MIndfullness and Jazz
EXPERIMENTALJazz Group 2 (Mindful Jazz) Group: Participants in this group will watch an introduction to jazz appreciation and mindfulness training video, including the use of jazz for pain tolerance prior to the 4-week intervention.
Waitlist
NO INTERVENTIONMusic Waitlist Group: Participants in this group will serve as a control and will not receive any intervention until the study is completed. They will complete a baseline survey and a follow-up survey at four weeks. Some videos will be sent to this group after the study is completed, without tracking their usage.
Interventions
All groups will complete a baseline and 4-week follow-up survey. Participants in Jazz Group 1 and Jazz Group 2 will engage in daily listening 4-week intervention.It is up to them if they want to listen to the daily recordings.
All groups will complete a baseline and 4-week follow-up survey. Participants in Jazz Group 1 and Jazz Group 2 will engage in daily listening 4-week intervention.They will have access to electronic audio recordings, with the order of listening labeled for each day. The recordings will increase gradually throughout the study, starting with about 10 minutes each day in the first week and reaching 30 minutes each day in the final week. The schedule is as follows: Week 1= 10 minutes, Week 2= 15 minutes, Week 3= 20 minutes Week 4= 30 minutes. It is up to them if they want to listen to the daily recordings.
Eligibility Criteria
You may qualify if:
- Are 18+
- Live in the US
- Are an English-proficient adult with a chronic pain diagnosis (no restrictions placed on type)
- Have a pain rating of four or greater in average pain on a 0-10 numeric rating scale in the preceding week
- Have had pain for at least 3 months and for at least 15 days in the preceding 30 days
- Have moderate to severe anxiety based on GAD-7
You may not qualify if:
- Are currently using or have used prescription opioids in the past 3 months to minimize a known treatment confound and increase sample homogeneity
- Have a current cancer diagnosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California Irvine
Irvine, California, 92868, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 28, 2023
First Posted
August 7, 2023
Study Start
August 1, 2023
Primary Completion
April 1, 2026
Study Completion
April 1, 2026
Last Updated
February 2, 2026
Record last verified: 2026-01